Atlas Trials

Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers

Clinical trial NCT04885829 · COMPLETED

Trial details

NCT number
NCT04885829
Sponsor
Syneos Health
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Rheumatoid ArthritisGiant Cell Arteritis
Start date
2021-05-31
Primary completion
2023-05-04
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.